|
Obagi Medical Products, Inc. - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Obagi Medical Products, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Obagi Medical Products, Inc.. The Group's principal activity is to develop and market prescription-based, topical skin health systems in the aesthetic and therapeutic skin health markets. It helps physicians to treat a range of skin conditions, including pre-mature aging, photo-damage, hyper pigmentation, acne and soft tissue deficits, such as fine lines and wrinkles. Its product lines are prescription-based skin health systems that improve the efficacy of established prescription and over-the-counter, therapeutic agents by enhancing the penetration of these agents across the skin barrier using proprietary technologies. It also licenses certain non-prescription product concepts under the Obagi trademark to a large Japanese based Pharmaceutical company. The Group introduced ELASTIdermTM product line, ELASTIdermTM Eye Cream, a for treatment of skin laxity around the eye.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
